Yingpai Pharmaceutical-B (07630) was increased by 100,000 shares by Executive Director and CEO Cai Suixiong

According to Zhitong Finance App, Yingpai Pharmaceutical-B (07630) issued an announcement. The board of directors was informed by Dr. Choi Suixiong, the company's executive director and CEO, that it had recently purchased a total of 100,000 shares of the company's common shares on the open market. The average price per share is about HK$14.6105, accounting for about 0.035% of the total number of shares issued by the company. Following the purchase, Dr. Choi held an interest in a total of 185.409 million shares, accounting for approximately 6.564% of the total issued share capital of the Company as of the date of this announcement.

Furthermore, Dr. Choi said that he is confident about the Group's overall development prospects and potential growth. Subject to applicable laws and regulatory requirements, Dr. Choi will not rule out further increasing his shareholding in the company in due course.